Sale of 100% stake of GENEPHARM S.A.

19/04/2019 Souriadakis Tsibris acted as the lead legal advisor in one of the most important M&A transactions in the Greek pharmaceutical sector for the first quarter of 2019.

ST represented the shareholders of GENEPHARM S.A., a major Greek generics pharmaceutical company, on the sale of their shares to MS PHARMA, an international pharmaceutical company based in Jordan and operating across the Middle East, Turkey and Africa. The transaction required specialised knowledge in relation to pharmaceutical products and services and an extensive experience in handling complex negotiations related to multiple jurisdictions.